Liver transplantation for erythropoietic protoporphyria liver disease

Liver Transplantation

Volumn 11, Issue 12, 2005, Pages 1590-1596

  McGuire, Brendan M ^a   Bonkovsky, Herbert L ^b   Carithers Jr , Robert L ^c   Chung, Raymond T ^d   Goldstein, Leonard I ^e   Lake, John R ^f   Lok, Anna S ^g   Potter, Carol J ^h   Rand, Elizabeth ⁱ   Voigt, Michael D ^j   Davis, Pamela R ^a   Bloomer, Joseph R ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h OHIO STATE UNIVERSITY   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j UNIVERSITY OF IOWA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMATIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; ERYTHROPOIETIC PROTOPORPHYRIA; FEMALE; GRAFT SURVIVAL; HUMAN; LIGHT DAMAGE; LIVER TRANSPLANTATION; MALE; NEUROPATHY; PATIENT CARE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENCE RISK; RETRANSPLANTATION; SCORING SYSTEM; SURVIVAL RATE; TISSUE INJURY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BONE MARROW; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROTOPORPHYRIA, ERYTHROPOIETIC; PROTOPORPHYRINS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 30444434611     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20620     Document Type: Article

References (39)

1. Gouya L, Puy H, Robreau AM, Bourgeois M, Lamoril J, Da Silva V, et al. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat Genet 2002;30:27-28.
2. Bloomer J, Bruzzone C, Zhu L, Scarlett Y, Magness S, Brenner D. Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation. J Clin Invest 1998;102: 107-114.
3. Risheg H, Chen FP, Bloomer JR. Genotypic determinants of phenotype in North American patients with erythropoietic protoporphyria. Mol Genet Metab 2003;80:196-206.
4. Morton KO, Schneider F, Weimer MK, Straka JG, Bloomer JR. Hepatic and bile porphyrins in patients with protoporphyria and liver failure. Gastroenterology 1988;94:1488-1992.
5. Shehade SA, Chalmers RJG, Prescott RJ. Predictable and unpredictable hazards of erythropoietic protoporphyria. Clin Exp Dermatol 1991;16:185-187.
6. Herbert A, Corbin D, Williams A, Thompson D, Bucckels J, Elias E. Erythropoietic protoporphyria: unusual skin and neurological problems after liver transplantation. Gastroenterology 1991;100:1753-1757.
7. Doss MO. Frank M. Hepatobiliary implications and complications in protoporphyria, a 20-year study. Clin Biochem 1989; 22:223-229.
8. Avner DL, Lee RG, Berenson MM. Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver. J Clin Invest 1981;67:385-394.
9. Avner DL, Larsen R, Berenson MM. Inhibition of liver surface membrane, Na, K-adenosine triphosphatase, Mg-adenosine triphosphatase and 5′-nucleotidase activities by protoporphyrin. Observations in vitro and in the perfused rat liver. Gastroenterology 1983;85:700-706.
10. Meerman L, Koopen NR, Bloks V, vanGoor H, Havinga R, Wolthers BG, et al. Biliary fibrosis associated with altered bile composition in a mouse model of Erythropoietic protoporphyria. Gastroenterology 1999;117:696-705.
11. Rank JM, Carithers R, Bloomer J. Evidence of neurologic dysfunction in end-stage protoporphyric liver disease. Hepatology 1993;18:1404-1409.
12. Wells MM, Golitz LE, Bender BJ. Erythropoietic protoporphyria with hepatic cirrhosis. Arch Dermatol 1980;116:429-32.
13. Polson RJ, Lim CK, Rolles K, Calne RY, Williams R. The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria. Transplantation 1988;46:386-389.
14. Bloomer JR, Weimer MK, Bossenmaier IC, Snover DC, Payne WD, Ascher NL. Liver transplantation in a patient with protoporphyria. Gastroenterology 1989;97:188-194.
15. Johnson JA, Fusaro RM. Liver transplantation in patients with erythropoietic protoporphyria. Gastroenterology 1990;96: 1726-1727.
16. Ozawa K, Uemoto S, Tanaka K, Kumada K, Yamaoka Y, Kobayashi N, et al. An appraisal of pediatric liver transplantation from living relatives. Ann Surg 1992;216:547-553.
17. Mion FBC, Faure JL, Berger R, McGragor B, Perrot H, Paliard P. Liver transplantation for erythropoietic protoporphyria. J Hepatol 1992;16:203-207.
18. Bloomer JR, Rank JM, Payne WD, Snover DC, Sharp HL, Zwiener RJ, Carithers RL. Follow-up after liver transplantation for protoporphyric liver disease. Liver Transpl Surg 1996;2:269-275.
19. Lock G, Holstege A, Jueller AR, Christe W, Doss MO, Scholmerich J, Neuhaus P. Liver failure in erythropoietic protoporphyria associated with choledocholithasis and severe post-transplantation polyneuropathy. Liver 1996;16:211-217.
20. Gross U, Frank M, Doss MO. Hepatic complications of erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed 1998;14:52-57.
21. Pratschke J, Steinmuller T, Bechstein WO, Neuhaus R, Tullius SG, Jonas S, et al. Orthotopic liver transplantation for hepatic associated metabolic disorders. Clin Transplant 1998;12:228-232.
22. Nguyen L, Blust M, Bailin M, Melendez L, Raines DE. Photosensitivity and perioperative polyneuropathy complicating orthotopic liver transplantation in a patient with erythropoietic protoporphyria. Anesthesiology 1999;91:1173-1175.
23. Samuel D, Boboc B, Bernau J, Bismuth H, Benhamou JP. Liver transplantation for protoporphyria. Evidence for the predominant role of the erythropoietic tissue in protoporphyrin over production. Gastroenterology 1988;95:816-819.
24. Torres ID, Demetris AJ, Randhawa PS. Recurrent hepatic allograft injury in erythropoietic protoporphyria. Transplantation 1996;61:1412-1413.
25. Rollwagen FM. Hepatic allograft injury in erythropoietic protoporphyria. Transplantation 1997;63:485-486.
26. Bloomer JR. Hepatic protoporphyrin metabolism in patients with advanced protoporphyric liver disease. Yale J Biol Med 1997,70:323-330.
27. Dellon ES, Szczepiorkowski ZM, Dzik WH, Graeme-Cook F, Ades A, Bloomer JR, et al. Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation 2002;73: 911-915.
28. Meerman L, Verwer R, Slooff MJH, van Hattum J, Beukeveld GJJ, Kleibeuker JH, Maagsma EB. Perioperative measures during liver transplantation for erythropoietic protoporphyria. Transplantation 1994;57:155-158.
29. Do KD, Banner EF, Katz E, Szymanski IO, Bonkovsky HL. Benefits of chronic plasmapheresis and intravenous heme-albumin in erythropoietic protoporphyria after orthotopic liver transplantation. Transplantation 2002;73:469-472.
30. Potter C, Tolaymat N, Bobo R, Sharp H, Rank J, Bloomer J. Hematin therapy in children with protoporphyric liver disease. J Pediatr Gastroenterol Nutr 1996:23:403-407.
31. Reichheld JH, Katz E, Banner BF, Szymanski IO, Saltzman JR, Bonkovsky HL. The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria. Transplantation 1999;67:922-928.
32. Muley SA, Midani HA, Rank JM, Carithers R, Parry GJ. Neuropathy in erythropoietic protoporphyrias. Neurology 1998;51: 262-265.
33. van den Besselaar AM. Precision and accuracy of the international normalized ratio in oral anticoagulant control. Haemostasis 1996;26:248-265.
34. Pawliuk R, Bachelot T, Wise RJ, Mathews-Roth MM, Leboulch P. Long-term cure of the photosensitivity of routine erythropoietic protoporphyria by preselective gene therapy. Nat Med 1999; 5:768-773.
35. Fontanellas A, Mazurier F, Landry M, Taine L, Morel C, Larou M, et al. Reversion of hepatobiliary alterations by bone marrow transplantation in a murine model of erythropoietic protoporphyria. Hepatology 2000;32:73-81.
36. Poh-Fitzpatrick MB, Wang X, Anderson KE, Bloomer JR, Bolwell B, Lichtin AE. Erythropoietic protoporphyria: altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutations. J Am Acad Dermatol 2002;46:861-866.
37. Appelbaum FR. The current status of hematopoietic cell transplantation. Annu Rev Med 2003;54:491-512.
38. Nemec P, Ondrasek J, Studenik P, Hokl J, Cerny J. Biliary complications in liver transplantation. Ann Transplant 2001;6:24-28.
39. Rerknimitr R, Sherman S, Fogel EL, Kalayci C, Lumeng L, Chalasani N, et al. Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy. Gastrointest Endosc 2002;55224-231.